首页> 外国专利> antibodies against il-13 alpha1 receptor, uses thereof, pharmaceutical composition, and method for its manufacture, recombinant host cell, nucleic acid, expression vector, method for the production of a polypeptide, as well as hybridoma cell line

antibodies against il-13 alpha1 receptor, uses thereof, pharmaceutical composition, and method for its manufacture, recombinant host cell, nucleic acid, expression vector, method for the production of a polypeptide, as well as hybridoma cell line

机译:抗il-13 alpha1受体的抗体,其用途,药物组合物及其制造方法,重组宿主细胞,核酸,表达载体,多肽的生产方法以及杂交瘤细胞系

摘要

ANTIBODIES AGAINST IL-13 ALPHA RECEPTOR, USES OF THE SAME, PHARMACEUTICAL COMPOSITION, AND METHOD FOR MANUFACTURING THE SAME, RECOMBINATING HOST CELL, NUCLEIC ACID, VECTOR EXPRESSION, HYDROPLE METHYDROID, METHOD The present invention relates to an antibody that binds IL-13Ral, inhibits IL-13 bioactivity and comprises a variable and light heavy chain variable characterized by the fact that the CDR3 variable heavy chain amino acid sequence of said The antibody is selected from the group consisting of the heavy chain CDR3 sequences of SEQ ID NO: 1, 3, 5, 7 or 9 and is useful in the treatment of asthma and allergic diseases.
机译:针对IL-13 Alpha受体的抗体,相同用途的药物组合物以及制造相同抗体的方法,重组宿主细胞,核酸,矢量表达,羟基甲基脂质,方法本发明涉及与IL-13Ral结合的抗体抑制IL-13生物活性,并包含可变和轻重链可变体,其特征在于所述抗体的CDR3可变重链氨基酸序列,该抗体选自SEQ ID NO:1的重链CDR3序列。 3、5、7或9,可用于治疗哮喘和过敏性疾病。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号